Thanks for all the work and great posts. I have followed this stock for many, many years. Sold for profit and then traded it a few more times. I'm thinking of getting back in, but waiting and researching current events. My longer term interest though is both investment and medically, as I have become friendly with several experts in the field of oncology after originally having my interest piqued when a close family member received a cancer diagnosis.
Here's what troubles me. Almost universally, when I speak to medical doctors, most affiliated with the biggest oncology centers, and whether they are oncologists, radiation oncologists, urologists, cancer surgeons and even internists, they universally are negative on this type of treatment, even in conjunction with other treatment.
When presented with some of the arguments you make so well, the response is often along these lines, "Where are the large randomized trials? Where are the JAMA studies? Docs and researchers thrive in today's environment on publication. Despite what many say about the influence of big pharma and big medical tech, if pomegranate or wine extract cures a cancer, there will be researchers jumping on it and publishing. "
As I said, I've followed this for many, many years, hoping that by now it would have gained more traction in the oncology community. Why hasn't it? It's easy to say that radiation oncologists think every patient should be radiated, that every surgeon thinks that every patient should be subject to an operation, etc., and I've used those arguments. In other words, "status quo, momentum, vested interests, red tape, etc."
I still can't get by the fact that this has been "out there" for many years and it has not gotten further along. If it really works, the argument goes, it would have been "discovered" by the medical community and the patients, particularly in these days of internet medical research by the general population.
I also have a more specific question that I have tried to get answered. After a cancer patient has localized radiation, typically a recurrence cannot be re-radiated because of the long term risk to surrounding organs and tissues. Has BSDM's treatment used (or is it contemplated) in this type of case, which is very common, particularly in prostate cancer treatment? Is there anything published to support this?
Thanks again for your answers and for your efforts and best of luck. |
